ResearcherFujian Medical UniversityActive in the last 2 years

Lili Su

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0002-1560-6729; OpenAlex author ID A5101007240. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

Multidisciplinary treatment incorporating autologous DC-CIK cell therapy induces long-term survival in advanced pancreatic cancer: a case report. Co-author DOI 10.3389/fimmu.2026.1908017 ↗
Integration of Protein-Protein Interaction Networks and Gene Expression Profiles Helps Detect Pancreatic Adenocarcinoma Candidate Genes. Co-author DOI 10.3389/fgene.2022.854661 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Shanshan Chen · 1 shared paper, 2026 · strength 0.30
- Paper Multidisciplinary treatment incorporating autologous DC-CIK cell therapy induces long-term survival in advanced pancrea… DOI 10.3389/fimmu.2026.1908017 ↗
Yang Sun · 1 shared paper, 2026 · strength 0.30
- Paper Multidisciplinary treatment incorporating autologous DC-CIK cell therapy induces long-term survival in advanced pancrea… DOI 10.3389/fimmu.2026.1908017 ↗
Jiayin Wang · 1 shared paper, 2022 · strength 0.19
- Paper Integration of Protein-Protein Interaction Networks and Gene Expression Profiles Helps Detect Pancreatic Adenocarcinoma… DOI 10.3389/fgene.2022.854661 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.